UBS Group upgraded shares of Fresenius Medical Care AG & Co. (NYSE:FMS) from a sell rating to a neutral rating in a research note released on Thursday, 99wallstreet.com reports.
Several other brokerages have also recently issued reports on FMS. Nord/LB reiterated a buy rating on shares of Fresenius Medical Care AG & Co. in a research report on Tuesday, January 2nd. SunTrust Banks set a $62.00 price target on Fresenius Medical Care AG & Co. and gave the company a buy rating in a research report on Thursday, December 21st. Morgan Stanley cut Fresenius Medical Care AG & Co. from an overweight rating to an equal weight rating in a research report on Monday, December 11th. DZ Bank reiterated a buy rating on shares of Fresenius Medical Care AG & Co. in a research report on Monday, December 18th. Finally, Zacks Investment Research cut Fresenius Medical Care AG & Co. from a hold rating to a sell rating in a research report on Tuesday, October 3rd. Five research analysts have rated the stock with a hold rating and five have issued a buy rating to the stock. The company currently has an average rating of Buy and a consensus price target of $55.67.
Shares of Fresenius Medical Care AG & Co. (NYSE FMS) traded up $0.29 during mid-day trading on Thursday, hitting $54.59. The stock had a trading volume of 130,587 shares, compared to its average volume of 150,420. Fresenius Medical Care AG & Co. has a one year low of $39.46 and a one year high of $54.81. The firm has a market cap of $33,345.09, a PE ratio of 24.48, a PEG ratio of 2.26 and a beta of 0.45. The company has a current ratio of 1.22, a quick ratio of 0.98 and a debt-to-equity ratio of 0.55.
ILLEGAL ACTIVITY NOTICE: “UBS Group Upgrades Fresenius Medical Care AG & Co. (FMS) to “Neutral”” was originally published by Community Financial News and is owned by of Community Financial News. If you are reading this story on another publication, it was illegally stolen and republished in violation of US & international trademark and copyright law. The legal version of this story can be read at https://www.com-unik.info/2018/01/08/ubs-group-upgrades-fresenius-medical-care-ag-co-fms-to-neutral.html.
About Fresenius Medical Care AG & Co.
Fresenius Medical Care AG & Co KGaA is a kidney dialysis company. The Company provides dialysis care and related services to persons suffering from end-stage renal disease (ESRD), as well as other healthcare services. The Company’s segments include North America Segment, the Europe, Middle East and Africa (EMEA) Segment, the Asia-Pacific Segment and the Latin America Segment.
What are top analysts saying about Fresenius Medical Care AG & Co.? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Fresenius Medical Care AG & Co. and related companies.